BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
PLOS ONE | www.plosone.org 1
January 2014 | Volume 9 | Issue 1 | e86616
International Journal of Infectious Diseases 80 (2019) 10–15
journal homepage: www.elsevier.com/locate/ijid
UNICEF’s Global HIV Response 2018 – 2021
Accessed: 02.11.2019
DHS Working Papers No. 127
Dziva Chikwari et al. Implementation Science (2018) 13:70 https://doi.org/10.1186/s13012-018-0762-5
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
guidance for health managers, health workers, and activists
“Follow the Voice of Life”
AIDSTAR-One | Case study series October 2011
A rapid situation analysis in three districts
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Of...fice of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
more
Djibuti et al. BMC Public Health (2015) 15:427 DOI 10.1186/s12889-015-1760-z
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in c...ertain countries of Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
more
Yu et al. BMC Public Health (2018) 18:825 https://doi.org/10.1186/s12889-018-5731-z
Research Article
Recommendations for a public health approach
2010 revision
Rueda S, et al. BMJ Open 2016;6:e011453. doi:10.1136/bmjopen-2016-011453
2018 monitoring report: current status and strategic priorities
The report sets out the status of women’s, children’s and adolescents’ h...ealth, and on health systems and social and environmental determinants. Regional dashboards on 16 key indicators highlight where progress is being made or lagging. There is progress overall, but not at the level required to achieve the 2030 goals. There are some areas where progress has stalled or is reversing, namely neonatal mortality, gender inequalities and health in humanitarian settings.
more
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society